foxo4-dri senolytic or senomorphic Frontiers FOXO4-DRI (Proxofim) 10mg*10 vials -
FOXO4 DRI (Proxofim) 10mg*10 vials Nexus peptides Your Gateway To High Quality Peptides Senolytics: charting a new course or enhancing existing anti tumor therapies? Cellular Oncology Springer Nature Link Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv FOXO4 DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53 serine 15 phosphorylation Communications Biology Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells eBioMedicine
Pay in 4 interest-free payments of $5.03 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4




